Digital Pathology Market is expected to reach US$ 1,892.40 million by 2028

Published on 12-Aug-2022
     Request For Sample

Report : Digital Pathology Market Share, Size and Growth Analysis By 2029

Technological Advancements in Digital Pathology Systems Drive Digital Pathology Market Growth

According to our latest study on "Digital Pathology Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Type, Application, and End User," the digital pathology market is expected to grow from US$ 952.62 million in 2022 to US$ 1,892.40 million by 2028; it is estimated to grow at a CAGR of 12.1% from 2022 to 2028. The rise in the demand for accurate diagnostics, and the development of new digital pathology systems by a large number of key players operating in the digital pathology market. However, the higher cost of digital pathology services is hampering the growth of the digital pathology market.

Computerization, robotic light microscopy, multiple fiber-optic communications, and digital imaging are among the technologies contributing to the modernization of digital pathology. Healthcare information technology (IT) helps physicians in maintaining optimal workflow, along with allowing them to meet the continuously changing patient expectations. The Aperio ePathAccess software offered by Leica Biosystems enables users to share digital pathology images and case data with experts outside the IT network. Further, frequent advancements in whole-slide imaging (WSI) technology, software applications, LIS/LIMS interface, and high-speed networking are allowing pathologists to fully integrate digital pathology into their workflows. The growing use of microarrays and predictive models, such as API algorithms and hybrid models, is bolstering the demand for digital image analysis. A computer-aided diagnosis integrates image processing with the concepts of physics and mathematics, and computational algorithms for disease diagnosis, anatomical evaluation, and disease progression quantification and risk assessment. Thus, the increasing popularity of computer-aided systems is supporting the digital pathology market growth.

Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F. Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; and Danaher Corporation are among the leading companies operating in the digital pathology market.

Based on product, the digital pathology market is segmented into scanner, software, storage, and communication systems. The scanner segment is further bifurcated into integrated and standalone. The scanner segment held the largest market share in 2021; however, the software segment is expected to register the highest CAGR during the forecast period. Based on type, the digital pathology market is bifurcated into human pathology and veterinary pathology. The human pathology segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period. Based on application, the digital pathology market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period. Based on end user, the digital pathology market is segmented into pharma & biotech companies, hospitals, and academics. The pharma & biotech companies segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period. Based on geography, the digital pathology market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The North American digital pathology market is further segmented into the US, Canada, and Mexico. The digital pathology market in Europe is subsegmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The APAC digital pathology market is subsegmented into China, India, Japan, Australia, South Korea, and the Rest of APAC. The digital pathology market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the MEA. The South & Central America digital pathology market is segmented into Brazil, Argentina, and the Rest of South & Central America.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com

Get Free Sample PDF

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?


Recent Posts